The fact that combination of metformin and FuOx markedly inhibits TCF/LEF activity and decreases β-catenin and c-myc levels suggests that Wnt/β-catenin signaling, which is greatly activated in many malignancies, including CRC [23], plays a pivotal role in regulating the tumor growth. The gene discussed is HNF4A; the disease is neoplasm.